Generally speaking, it is always preferable to opt for the fewest possible doses of a long-term medication a day.  Adherence is improved. So the introduction by Novartis of a new once a day long-acting beta-adrenoceptor agonist for people with chronic … Continue reading

A recent article about a possible new lipid-modifying drug has raised several important issues.  Here are some of the relevant remarks from an article in the Daily Telegraph: “early trials of (the) drug, called torcetrapib, showed that, when given in … Continue reading

A relatively new drug called ranibizumab (Lucentis) can cause an improvement in diabetic macular œdema when it is injected into the eye.  According to this article, the National Institute for Health and Clinical Excellence (NICE) has just recommended that NHS … Continue reading

Drugs are having a bad time this year.  The latest batch to come under the hammer are Non-Steroidal Anti-inflammatory Drugs (NSAID) in general and Ibuprofen in particular.   An observational trial has revealed a higher incidence of atrial fibrillation in people … Continue reading

Here is the final bulletin from Linda Goldie at the ADA. On the last full day I went to a series of lectures called ‘Is there a Gold Standard for the Diagnosis of Diabetes’. As you are aware the ADA … Continue reading